Literature DB >> 19804393

Endonasal endoscopic management of contact point headache and diagnostic criteria.

Alireza Mohebbi1, Framarz Memari, Saleh Mohebbi.   

Abstract

BACKGROUND: Some types of headaches with sinonasal origin may be present in the absence of inflammation and infection. The contact points between the lateral nasal wall and the septum could be the cause of triggering and sustained pain via trigeminovascular system.
OBJECTIVE: The aim of this study was to evaluate the feasibility and effectiveness of endoscopic surgery in the sinonasal region for treatment of headache with special attention paid to specific diagnostic methods and patient selection.
METHODS: This was a prospective, non-randomized and semi-quasi experimental research study. Thirty-six patients with chronic headaches who had not previously responded to conventional treatments were evaluated by rhinoscopy and/or endoscopy, local anesthetic tests and computed tomography scans as diagnostic criteria. These patients were divided into 4 groups based on the diagnostic methods utilized. The intensity of headaches pre- and post-operatively were recorded by utilizing the visual analog scale scale and performing analysis with analysis of variance test comparison and Statistical Package for Social Sciences. Average follow-up was 30 months.
RESULTS: Our overall success rate approximated 83% while the complete cure rate was 11%. Patients in group 4 achieved the best results. In this group all diagnostic criteria were positive. In addition, patient responses were statistically significant in groups with more than one positive criteria compared with group 1 who only had positive examination. The positive response of 14 migrainous patients diagnosed with migraine prior to treatment was 64%.
CONCLUSION: Surgery in specific cases of headaches with more positive evidence of contact point could be successful, particularly if medical therapy has failed.

Entities:  

Mesh:

Year:  2009        PMID: 19804393     DOI: 10.1111/j.1526-4610.2009.01520.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

1.  Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis: does it confound outcomes assessment?

Authors:  Luke Rudmik; Jess Mace; Berrylin J Ferguson; Timothy L Smith
Journal:  Laryngoscope       Date:  2011-10-27       Impact factor: 3.325

2.  Mechanophysical stimulations of mucin secretion in cultures of nasal epithelial cells.

Authors:  Nurit Even-Tzur Davidovich; Yoel Kloog; Michael Wolf; David Elad
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

Review 3.  Nose and headache: what have we learned? Naso e cefalee: cosa abbiamo imparato.

Authors:  Carlotta Pipolo; Sara Portaleone; Giovanni Felisati
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

4.  Endoscopic management of contact point headache in patients resistant to medical treatment.

Authors:  Mohammad Sadeghi; Babak Saedi; Yasser Ghaderi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-02-28

Review 5.  Endoscopic surgical treatment for rhinogenic contact point headache: systematic review and meta-analysis.

Authors:  Antonino Maniaci; Federico Merlino; Salvatore Cocuzza; Giannicola Iannella; Claudio Vicini; Giovanni Cammaroto; Jérome R Lechien; Christian Calvo-Henriquez; Ignazio La Mantia
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-06       Impact factor: 2.503

6.  Effect of turbinoplasty in concha bullosa induced rhinogenic headache, a randomized clinical trial.

Authors:  Mohammad Ebrahim Yarmohammadi; Hassan Ghasemi; Shahryar Pourfarzam; Mohammad Reza Jalali Nadoushan; Siamak Afshin Majd
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

7.  Changes in substance P levels of inferior turbinate in patients with mucosal contact headache.

Authors:  Hülya Eyigör; Mete Eyigör; Bekir Erol; Ömer Tarık Selçuk; Levent Renda; Mustafa Deniz Yılmaz; Üstün Osma; Cansu Demirkıran; Meral Gültekin; Nuray Erin
Journal:  Braz J Otorhinolaryngol       Date:  2019-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.